Back

What is on the horizon for HFrEF therapy?

29 August 2025 (09:09 - 09:27)
Organised by: Logo
Congress Presentation Part of: HFrEF treatment: where are we and where are we going? Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
What is current guideline-recommended medical therapy for HFrEF?
Professor J. Bauersachs (Hannover, DE)
Slides Video
Presentation thumbnail
How should we best optimise therapy for HFrEF?
Professor M. Arrigo (Bellinzona, CH)
Slides Video
Presentation thumbnail
When should we downtitrate or stop HFrEF therapy?
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
HFrEF treatment: where are we and where are we going? - discussion
Video

Access the full session

Session thumbnail
HFrEF treatment: where are we and where are we going?
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 09:09 CET
You may be interested in
thumbnail
Congress Presentation
What can we expect from future clinical trials in heart failure?
18 May 2025
thumbnail
Congress Presentation
What is the 'contemporary era' of HFrEF?
9 May 2026
thumbnail
Congress Presentation
Has the time arrived for a “three-pillar” approach to manage HFpEF?
1 September 2024
thumbnail
Congress Presentation
New treatments on the horizon - discussion
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources